Isis Pharmaceuticals Net Income Quarterly:
-1.672M for March 31, 2013Isis Pharmaceuticals Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -1.672M |
| Dec. 31, 2012 | -2.637M |
| Sept. 30, 2012 | -37.64M |
| June 30, 2012 | -1.207M |
| March 31, 2012 | -24.00M |
| Dec. 31, 2011 | -20.04M |
| Sept. 30, 2011 | -26.88M |
| June 30, 2011 | -17.89M |
| March 31, 2011 | -19.99M |
| Dec. 31, 2010 | -13.99M |
| Sept. 30, 2010 | -12.45M |
| June 30, 2010 | -25.15M |
| March 31, 2010 | -9.658M |
| Dec. 31, 2009 | -16.84M |
| Sept. 30, 2009 | -11.58M |
| June 30, 2009 | -2.73M |
| March 31, 2009 | 186.22M |
| Dec. 31, 2008 | -10.26M |
| Sept. 30, 2008 | 1.613M |
| June 30, 2008 | -3.737M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
ISIS Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Aegerion Pharmaceuticals | -18.14M |
| Sanofi | 1.287B |
| Biogen Idec | 426.75M |
ISIS Net Income Quarterly Rankings
| Overall |
44th percentile 4232 of 7590 |
| Sector |
44th percentile 360 of 651 in Healthcare |
| Industry |
63rd percentile 86 of 238 in Biotechnology |
ISIS Net Income Quarterly Range, Past 5 Years
| Minimum | -37.64M | Sep 2012 |
| Maximum | 186.22M | Mar 2009 |
| Average | -3.526M |
